GL
Therapeutic Areas
Zhimeng Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZM-H1505R | Chronic Hepatitis B | Phase 1 |
| Undisclosed CAM | Chronic Hepatitis B | Clinical |
| Undisclosed Immunomodulator | Chronic Hepatitis B | Clinical |
| Undisclosed Program | Refractory Epilepsy | Clinical |